176 related articles for article (PubMed ID: 10430010)
1. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group.
Casper F; Petri E
Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(3):171-6. PubMed ID: 10430010
[TBL] [Abstract][Full Text] [Related]
2. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
3. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
Smith P
Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
[TBL] [Abstract][Full Text] [Related]
4. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.
Henriksson L; Stjernquist M; Boquist L; Cedergren I; Selinus I
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):85-92. PubMed ID: 8572039
[TBL] [Abstract][Full Text] [Related]
5. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
Casper F; Petri E; Benninghoff B
Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
[TBL] [Abstract][Full Text] [Related]
6. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
7. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
9. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.
Bachmann G
J Reprod Med; 1998 Nov; 43(11):991-8. PubMed ID: 9839269
[TBL] [Abstract][Full Text] [Related]
10. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.
Pinkerton JV; Shifren JL; La Valleur J; Rosen A; Roesinger M; Siddhanti S
Menopause; 2003; 10(1):45-52. PubMed ID: 12544676
[TBL] [Abstract][Full Text] [Related]
11. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
Smith P; Heimer G; Lindskog M; Ulmsten U
Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
[TBL] [Abstract][Full Text] [Related]
12. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.
Speroff L
Obstet Gynecol; 2003 Oct; 102(4):823-34. PubMed ID: 14551014
[TBL] [Abstract][Full Text] [Related]
14. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
Barentsen R; van de Weijer PH; Schram JH
Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
[TBL] [Abstract][Full Text] [Related]
15. The estradiol vaginal ring--a study of existing clinical data.
Bachmann G
Maturitas; 1995 Dec; 22 Suppl():S21-9. PubMed ID: 8775773
[TBL] [Abstract][Full Text] [Related]
16. Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.
Cortés-Bonilla M; Bernardo-Escudero R; Alonso-Campero R; Francisco-Doce MT; Hernández-Valencia M; Celis-González C; Márquez-Oñate R; Chedraui P; Uribe JA
Gynecol Endocrinol; 2015 Jul; 31(7):552-9. PubMed ID: 26062108
[TBL] [Abstract][Full Text] [Related]
17. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.
Diem SJ; Guthrie KA; Mitchell CM; Reed SD; Larson JC; Ensrud KE; LaCroix AZ
Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial of the estradiol vaginal ring in the U.S.
Nachtigall LE
Maturitas; 1995 Dec; 22 Suppl():S43-7. PubMed ID: 8775777
[TBL] [Abstract][Full Text] [Related]
19. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol.
Griesser H; Skonietzki S; Fischer T; Fielder K; Suesskind M
Maturitas; 2012 Apr; 71(4):360-8. PubMed ID: 22285095
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
